KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Collaborators

Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group:
Jürgen Floege, David R W Jayne, Jan-Stephan F Sanders, Vladimír Tesar, Brad H Rovin

Free article

Practice Guideline

Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. Kidney Int. 2024 Mar.

Free article

. 2024 Mar;105(3S):S71-S116.

doi: 10.1016/j.kint.2023.10.008.

Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group:
Jürgen Floege, David R W Jayne, Jan-Stephan F Sanders, Vladimír Tesar, Brad H Rovin

Erratum in

Corrigendum to "KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis." Kidney International 2024;105(3S):S71-S116.
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. Kidney Int. 2024 Jul;106(1):160-163. doi: 10.1016/j.kint.2024.04.003. Epub 2024 May 13. Kidney Int. 2024. PMID: 38739061 No abstract available.
Corrigendum to "KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis." Kidney International 2024;105(3S):S71-S116.
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. Kidney Int. 2025 Feb;107(2):367. doi: 10.1016/j.kint.2024.10.004. Kidney Int. 2025. PMID: 39848754 No abstract available.

No abstract available